ArticleACS ES&T air2025
Factors Affecting Reduction of Infectious Aerosols by Far-UVC and Portable HEPA Air Cleaners.
Article in ACS ES&T air, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Technologies that can reduce concentrations of airborne microorganisms through either particle capture or inactivation are important tools for reducing the risk of disease transmission and improving overall indoor air quality. The effectiveness of these technologies is tested in different ways, and as a result, it is challenging to compare results and optimize their use in applied settings. In this study, experiments were conducted in a large bioaerosol chamber to evaluate the efficacy of far-UVC and portable HEPA air cleaners against the bacteriophage MS2 as a surrogate for human viral pathogens. For both technologies, changing the media used to aerosolize the microorganism from deionized water to a simulated saliva doubled effectiveness metrics (both log
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.